Novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
CA2807263A1
Novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
WO2011009956A1
Injectable aqueous solution containing artesunate
EP2289554A1
Compositions comprising thalidomide and artemisinin for the treatment of cancer
WO2011006536A1
Pyridyl-substituted isoquinoline derivatives with activity againstmycobacteriaand especially myobacterium tuberculosis
WO2010149215A1
Artesunate pharmaceutical compositions soluble in aqueous solutions
EP2197885A1
Increasing the in vivo biological activity of biologically active compounds
NL1035408C2
New isoquinoline derivative useful for producing prodrug for preventing and/or treating tuberculosis e.g. open pulmonary tuberculosis
WO2009033494A1
1- or 2-substituted artemisinin derivatives for increasing the in vivo biological activity of biologically active compounds
AP200704032A0
Pharmaceutical carrier composition and pharmaceutical composition
NL1033569C1
Synthesis of intermediates of artemisin, used for fighting malaria, comprises isolating intermediates from chicory plant which produces amorpha-4,11-dienes
WO2008098586A1
Pharmaceutical carrier composition and pharmaceutical composition
EP1940519A1
Pharmaceutical composition comprising artesunate, sulfamethoxypyrazine and pyrimethamine for use in the treatment of malaria within one day
ZA200802108B
Pharmaceutical composition suitable for the treatment of malaria within one day
